Colorectal Cancer Diagnostics Market
Medical Device

Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Mayur SComments Off on Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Medtronic Plc and Boston Scientific Corporation – Notable Market Players in Colorectal Cancer Diagnostics Market

Key driving factors include the factors driving the colorectal cancer diagnostics market growth are increasing prevalence of colorectal cancer and launches of new products. However, the low accuracy of screening based on fecal immunochemical tests (FITs)hinders the colorectal cancer diagnostics market growth. 

The colorectal cancer diagnostics market is majorly comprised of top players involving Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd. among others.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the colorectal cancer diagnostics market:       

Year

News

March 2023

Sengkang General Hospital collaborate with Medtronic promote AI-assisted colonoscopies.
The two organizations have signed a memorandum of understanding to promote AI-assisted colonoscopy
for colorectal cancer screening.

August 2021

Illumina Acquired GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test.
GRAIL’s Galleri blood test detects 50 different cancers before they are symptomatic. Illumina’s acquisition of
GRAIL will accelerate access and adoption of this life-saving test worldwide.

January 2020

Illumina, Roche Launched NGS-Based Cancer Diagnostics Partnership. Illumina and Roche have
signed a 15-year, non-exclusive collaboration agreement designed to realize next-generation
sequencing’s potential to transform cancer risk prediction, detection, diagnosis, treatment, and monitoring.

April 2020

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics for Innovative First-Line Colorectal Cancer Screening Blood Test.
The alliance also expands the company’s commercialization rights for hte Trident Program and COLVERA for CRC monitoring outside the US,
Mexico, UK, and India.

 

Mayur S
https://www.theinsightpartners.com/

Related Articles
Medical Device

Linear Accelerator Market – Understanding the Competitive Scenario in Medical Device Industry

The Insight Partners

A linear accelerator system enables to boost the charged particles through a linear trajectory with the application of electromagnetic fields. They are used in various industries, especially for non-destructive testing (NDT), which performed to assess the properties of a diverse material without damaging them. The increasing use of scanning equipment in several industries and growing […]

Infusion Pumps market
Medical Device

The Infusion Pumps Market Is Estimated to Grow with a CAGR of 6.2% from 2016-2025

The Insight Partners

Increasing number of surgical procedures is expected to enhance the growth of infusion pumps market from 2018 to 2025. The global infusion pumps market is expected to reach US$ 18,045.6 Mn in 2025 from US$ 11,378.8 Mn in 2017. The market is expected to witness growth due to rise in the number of surgical procedures […]

Medical Imaging Market
Medical Device

4.3% CAGR, Medical Imaging Market is Emerging with Increasing Demand for Early Diagnosis by 2028

The Insight Partners

  Medical imaging refers to techniques and processes used to create images of various parts of the human body for diagnostic and treatment purposes within digital health. The term, medical imaging, includes various radiological imaging techniques such as: X-ray radiography, Fluoroscopy, Magnetic resonance imaging (MRI), Medical ultrasonography or ultrasound, Endoscopy, Elastography, Tactile imaging, Thermography, Medical […]